Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening
Journal of Medical Virology · 2024-01 · 96 (1)
DOI: 10.1002/jmv.29382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 18.01.2024. Verfasst von Chunhong Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China. Hauptthemen laut MEDLINE: Encephalitis Virus, Japanese, Encephalitis, Japanese. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STS Regional Key Project, National Key Research and Development Program of China.
Abstract (Originalsprache)
Japanese encephalitis (JE) caused by JE virus (JEV), remains a global public health concern. Currently, there is no specific antiviral drug approved for the treatment of JE. While vaccines are available for prevention, they may not cover all at‐risk populations. This underscores the urgent need for prophylaxis and potent anti‐JEV drugs. In this context, a high‐content JEV reporter system expressing Nanoluciferase (Nluc) was developed and utilized for a high‐throughput screening (HTS) of a commercial antiviral library to identify potential JEV drug candidates. Remarkably, this screening process led to the discovery of five drugs with outstanding antiviral activity. Further mechanism of action analysis revealed that cepharanthine, an old clinically approved drug, directly inhibited virus replication by blocking GTP binding to the JEV RNA‐dependent RNA polymerase. Additionally, treatment with cepharanthine in mice models alleviated JEV infection. These findings warrant further investigation into the potential anti‐JEV activity of cepharanthine as a new therapeutic approach for the treatment of JEV infection. The HTS method employed here proves to be an accurate and convenient approach that facilitates the rapid development of antiviral drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
- University of the Chinese Academy of Sciences, Beijing, China.
- School of Basic Medical Sciences, Cixi Biomedical Research Institute, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Hubei Jiangxia Laboratory, Wuhan, China.
ORCID-Profile: Chunhong Yin
Förderung
- STS Regional Key Project
- National Key Research and Development Program of China
Zitieren
APA
Yin, C., Yang, P., Xiao, Q., Sun, P., Zhang, X., Zhao, J., Hu, X., & Shan, C. (2024). Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening. Journal of Medical Virology, 96(1). https://doi.org/10.1002/jmv.29382
Vancouver
Yin C, Yang P, Xiao Q, Sun P, Zhang X, Zhao J, et al. Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening. Journal of Medical Virology. 2024;96(1). doi:10.1002/jmv.29382
BibTeX
@article{Yin2024,
author = {Yin, Chunhong and Yang, Peipei and Xiao, Qingcui and Sun, Peng and Zhang, Xuekai and Zhao, Jiaxuan and Hu, Xue and Shan, Chao},
title = {Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus‐based high‐throughput screening},
journal = {Journal of Medical Virology},
year = {2024},
volume = {96},
number = {1},
doi = {10.1002/jmv.29382}
}
EUVIMED